Merck, Daiichi Sankyo Ink $5.5 Billion Oncology Deal, Shares Soar for Both Companies

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

Related Keywords

Tokyo ,Japan ,Daiichi Sankyo ,Sunao Manabe ,Astrazeneca ,Reuters ,Drugmaker Merck ,Revenue Target ,Gains Access ,Real Time Economy News ,Orex News ,Igital Currency News ,Conomy Research ,Conomy Commentaries ,